InMed Pharmaceuticals Inc. Quarterly Return On Assets in % from Q1 2021 to Q4 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
InMed Pharmaceuticals Inc. quarterly/annual Return On Assets history and growth rate from Q1 2021 to Q4 2023.
  • InMed Pharmaceuticals Inc. Return On Assets for the quarter ending December 31, 2023 was -46.2 %, a 59.3% increase year-over-year.
  • InMed Pharmaceuticals Inc. annual Return On Assets for 2023 was -52.7 %, a 54% increase from 2022.
  • InMed Pharmaceuticals Inc. annual Return On Assets for 2022 was -114 %, a 13.5% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2023 -46.2 +67.3 +59.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -49.2 +73.8 +60% Jul 1, 2023 Sep 30, 2023
Q2 2023 -52.7 +61.8 +54% Apr 1, 2023 Jun 30, 2023
Q1 2023 -105 -14.6 -16.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -113 -20.9 -22.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -123 -32.6 -36% Jul 1, 2022 Sep 30, 2022
Q2 2022 -114 -13.7 -13.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -90.3 -1.34 -1.51% Jan 1, 2022 Mar 31, 2022
Q4 2021 -92.6 Oct 1, 2021 Dec 31, 2021
Q3 2021 -90.4 Jul 1, 2021 Sep 30, 2021
Q2 2021 -101 Apr 1, 2021 Jun 30, 2021
Q1 2021 -88.9 Jan 1, 2021 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.